Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

112.52
Delayed Data
As of Aug 04
 -0.71 / -0.63%
Today’s Change
58.16
Today|||52-Week Range
133.98
+66.25%
Year-to-Date

Today’s Trading

Previous close113.23
Today’s open112.48
Day’s range110.51 - 113.23
Volume276,122
Average volume (3 months)324,126
Market cap$2.5B
Dividend yield--
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-107.16%
Earnings growth (next 5 years)+3.13%
Revenue growth (last year)+17.13%
P/E ratio--
Price/Sales23.78
Price/Book8.69

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc+0.52+0.93%
MYGNMyriad Genetics Inc-0.85-2.51%
TSROTESARO Inc+0.53+0.91%
--COSMO Pharmaceutical...+1.20+0.75%
Data as of 08/04/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$49.9M
Annual profit (last year)-$24.4M
Net profit margin-48.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts